Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/D130ACBA.svg?ark=w1%2F20260515%2FD130ACBA)](https://nobleid.org/work/w1/20260515/D130ACBA)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors